QOL Medical, LLC   Report issue

Contributed to NME For profit Phase 4
Founded: Vero Beach FL United States (2003)
Status: Acquired by Nautic Partners (2013)

Organization Overview

First Clinical Trial
2016
NCT02784067
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

QOL MEDCL | QOL Medical | QOL Medical, LLC | QOL meds

Active Ingredients

Marketed Drugs (2)

ethanolamine (ethamolin) (1988 NDA)

sacrosidase (sucraid) (1998)

Drugs in Phase 4 Trials (1)

sacrosidase (sucraid) (4 trials)

Indications

Approved Indications


 

Esophageal and Gastric Varices

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carbohydrate Metabolism, Inborn Errors (Phase 4)

Diarrhea (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 1